Generali Investments CEE’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.6M Sell
31,551
-2,623
-8% -$519K 0.31% 93
2026
Q1
$5.62M Buy
34,174
+3,000
+10% +$519K 0.29% 98
2025
Q4
$5.53M Sell
31,174
-11,000
-26% -$1.83M 0.39% 72
2025
Q3
$6.7M Buy
42,174
+13,774
+49% +$2.03M 0.51% 53
2025
Q2
$4M Hold
28,400
0.33% 99
2025
Q1
$3.31M Sell
28,400
-2,000
-7% -$258K 0.31% 109
2024
Q4
$3.82M Buy
+30,400
New +$3.74M 0.39% 83

Other funds holding MS

Generali Investments CEE's MS Position: Q2 2026 in Review

Generali Investments CEE reduced its Morgan Stanley (MS) stake by 7.7% in Q2 2026, selling an estimated $519K and leaving 31,551 shares worth $6.6M. The position accounts for 0.31% of the portfolio, ranked #93.

Generali Investments CEE first reported a position in MS in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.7M in Q3 2025. 2,740 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Generali Investments CEE held 31,551 shares of Morgan Stanley worth $6.6M as of Q2 2026.
  • Generali Investments CEE sold 2,623 Morgan Stanley shares in Q2 2026, an estimated $519K.
  • Morgan Stanley made up 0.31% of Generali Investments CEE's portfolio in Q2 2026, its #93 holding.
  • Generali Investments CEE first reported a position in Morgan Stanley in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments CEE's Morgan Stanley position peaked at $6.7M in Q3 2025.
  • 2,740 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.